TINAGL1 activators are a class of chemicals that enhance the functional activity of TINAGL1, a protein that is involved in the PI3K/Akt and mTOR signaling pathways. These activators can either act directly on TINAGL1 itself or indirectly by affecting the PI3K/Akt and mTOR signaling pathways that TINAGL1 is a part of. Direct activators include ATP and Phosphatidic Acid, both of which enhance TINAGL1's functional activity by regulating the PI3K/Akt pathway, and Insulin, which is a well-known activator of the PI3K/Akt pathway. These direct activators increase TINAGL1's functional activity by triggering signaling events that lead to its activation.
Indirect activators of TINAGL1 include Lithium Chloride, which inhibits GSK3β, and thus enhances the activation of the PI3K/Akt pathway and subsequently TINAGL1. Akt Inhibitor IV, PF-04691502, PI-103, NVP-BEZ235, and Perifosine are all potent inhibitors of PI3K, mTOR, or Akt. By inhibiting these kinases, these indirect activators enhance the functional activity of TINAGL1. It is important to note that while these activators do not directly activate TINAGL1, they play crucial roles in the signaling cascade that ultimately leads to its activation. These activators enable the fine-tuning of the PI3K/Akt and mTOR signaling pathways, thereby indirectly influencing the functional activity of TINAGL1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 5′-Triphosphate, disodium salt | 987-65-5 | sc-202040 sc-202040A | 1 g 5 g | $39.00 $75.00 | 9 | |
ATP is a small molecule that serves as the main energy currency of the cell. ATP can regulate phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway. TINAGL1 is involved in PI3K/Akt pathway and thus, ATP can indirectly enhance the functional activity of TINAGL1. | ||||||
1,2-Dipalmitoyl-rac-glycero-3-phosphocholine | 2644-64-6 | sc-207591 sc-207591A | 100 mg 250 mg | $86.00 $129.00 | ||
Phosphatidic Acid is a simple phospholipid that plays a crucial role in cellular signaling. It is a potent activator of the mTOR pathway, which TINAGL1 is known to be involved in. Hence, Phosphatidic Acid can indirectly enhance the functional activation of TINAGL1. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride is a chemical compound that is known to inhibit GSK3β. GSK3β is an inhibitor of the PI3K/Akt pathway, thus, inhibition of GSK3β by Lithium Chloride can enhance the activation of the PI3K/Akt pathway, and subsequently TINAGL1. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin is a hormone that is a known activator of the PI3K/Akt pathway, which is involved in the functional activity of TINAGL1. | ||||||
Akt Inhibitor IV | 681281-88-9 | sc-203809 sc-203809A | 5 mg 25 mg | $176.00 $709.00 | 42 | |
Akt Inhibitor IV is a potent inhibitor of Akt phosphorylation. By inhibiting Akt, this compound indirectly enhances the functional activation of TINAGL1. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $33.00 $131.00 | 3 | |
PI-103 is a potent inhibitor of PI3K and mTOR. By inhibiting these kinases, PI-103 can indirectly enhance the functional activation of TINAGL1. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $211.00 | 8 | |
NVP-BEZ235 is a dual PI3K/mTOR inhibitor which can indirectly enhance the functional activation of TINAGL1. | ||||||
Perifosine | 157716-52-4 | sc-364571 sc-364571A | 5 mg 10 mg | $188.00 $327.00 | 1 | |
Perifosine is a novel Akt inhibitor. By inhibiting Akt, Perifosine can indirectly enhance the functional activation of TINAGL1. | ||||||